Press "Enter" to skip to content

Cancer Diagnostics Market 2019 Significant Growth Rate by Industry Size, Share, Market Dynamics, Development Status of Key Players Forecast to 2024

Cancer

The “Cancer Diagnostics Market” 2019 report provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries. Cancer Diagnostics Market report also aims to provide useful and comprehensive insights into current market trends and future growth scenarios. Cancer Diagnostics market report contains information like SWOT analysis, business highlights, strength, weakness, threats and opportunities of industry.

Top Manufacturers of Cancer Diagnostics Market Are:

  • Abbott
  • Qiagen
  • F. Hoffmann
  • La Roche Ltd
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Hologic Inc.
  • Illumina Inc
  • Philips Healthcare
  • Agilent Technologies Inc

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244211

    Market Overview:

  • Increase in the number of cancer cases and the rise in geriatric population are the major factors which are attributing for the growth of the Cancer Diagnostics market globally. As per the WHO statistics, cancer accounts for 13% of deaths globally every year, moreover, 70% increase in cancer incidences is anticipated over the next couple of decades and global geriatric population is anticipated to nearly double from 12% to 22% from 2015 to 2022. Furthermore, increase in the emergence of new technologies like biomarkers and point of care testing, inclination towards advanced less-painful and way more efficient tests from conventional tests, improved healthcare expenditure, growing awareness, and increased government support are the few more factors which are boosting the growth of the Cancer Diagnostics market globally. However, stringent regulatory framework, lack of universal health coverage, expensive diagnostic procedures, prolonged time of approvals for product launching and cost containment measures are the few factors restraining the growth of Cancer Diagnostics market globally.

    Scope of the Report:

  • Cancer is a complex disease that impacts every patient differently. Comprehensive and personalized treatment starts with an accurate, thorough diagnosis that includes radiology, pathology, genetics and advanced genomic testing. Sophisticated tests and procedures are used to measure the stage and progression of the disease and identify the tumor’s type, size, and location.
  • Cancer diagnosis begins with a thorough physical exam and a complete medical history. Laboratory studies are performed to detect abnormalities that may indicate cancer. When a tumor is suspected, imaging tests help doctors to determine cancer’s location and size. To confirm the diagnosis of most cancers, a biopsy needs to be performed in which a tissue sample is removed from the suspected tumor and studied under a microscope to check for cancer cells. If the diagnosis is positive (cancer is present), other tests are performed to provide specific information about cancer. If the initial diagnosis is positive for cancer and symptoms persist, further tests may be needed and the further treatment is started.

    Cancer Diagnostics Market Report Answers the Following Questions:

    • What will the market size and the growth rate be in 2024?
    • What are the key factors driving the global Cancer Diagnostics market?
    • What are the key market trends impacting the growth of the global Cancer Diagnostics market?
    • What are the challenges to market growth?
    • Who are the key vendors in the global Cancer Diagnostics market?
    • What are the market opportunities and threats faced by the vendors in the global Cancer Diagnostics market?
    • Trending factors influencing the market shares of the relevant regions.
    • What are the key outcomes of the five forces analysis of the global Cancer Diagnostics market?

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14244211

    Key Market Trends:

    Imaging Test is expected to dominate the Cancer Diagnostics Market

    The most commonly used screening test for cancer is diagnostic imaging tests. The different kinds of imaging techniques for cancer detection are Imaging (Radiology) Tests for Cancer, CT Scans, MRI, Nuclear Medicine Scans, Ultrasound, Mammograms, X-rays and Other Radiographic Tests and are considered as the most reliable ones. Factors that are responsible for the growth of this segment include the increasing awareness about the early detection of cancer, the growing incidence of various types of cancer, and the increasing government initiatives and support. Mammograms are the most widely used tests to diagnose cancers. Mammography is the gold standard technique used to screen breast cancer, governments and other healthcare organizations around the world are taking initiatives to provide women, between the ages of 50 and 75, access to mammography screening. As per the Breastcancer.org, about one in eight US women (about 12.4%) will develop invasive breast cancer over the course of their lifetime. In 2018, an estimated 266,120 new cases of invasive breast cancer are anticipated to be diagnosed in women only in the United States, along with 63,960 new cases of non-invasive breast cancer.

    The Asia Pacific is anticipated to grow rapidly in the global Cancer Diagnostics market

    Asia-Pacific is expected to record a substantial growth over the forecast period, due to the existence of a large patient pool, availability of skilled professionals at a reasonable cost, and a distinct regulatory framework supporting accelerated product approvals and growing economic developments in countries like China and India and improved healthcare infrastructure. According to India Against Cancer report, total deaths due to cancer in 2018 in India are 7, 84,821 out of which 4,13,519 are Men and 3,71,302 are Women. Market players in the APAC region are involved in partnerships and agreements to enhance the market growth in Cancer Diagnostics. For instance, In April 2019, Halifax signs an exclusive agreement with Genecast to make Immunoscore® available in China. In June 2017, Agilent Technologies Inc. and Agendia, Inc. have entered into an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint and BluePrint tests.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Cancer Diagnostics Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Cancer Diagnostics .

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14244211

    Report Objectives:

    • Analyzing the size of the Cancer Diagnostics market on the basis of value and volume.
    • Accurately calculating the market segments, consumption, and other dynamic factors of different sections of the global Cancer Diagnostics market.
    • Determining the key dynamics of the Cancer Diagnostics market.
    • Highlighting significant trends of the Cancer Diagnostics market in terms of manufacture, revenue, and sales.
    • Deeply summarizing top players of the Cancer Diagnostics market and showing how they compete in the industry.
    • Studying industry processes and costs, product pricing, and various trends related to them.
    • Displaying the performance of different regions and countries in the global Cancer Diagnostics market.

    Detailed TOC of Cancer Diagnostics Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Ease of Cancer Diagnosis
    4.2.2 ncreasing Healthcare Expenditure
    4.2.3 Emergence of New Technologies such as Biomarkers and Point of Care Testing
    4.3 Market Restraints
    4.3.1 Limited Use in the Emerging Markets
    4.3.2 Expensive Diagnostic Procedures
    4.4 Porter’s Five Force Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Diagnotic Type
    5.1.1 Diagnostic Imaging Tests
    5.1.2 Biopsy and Cytology Tests
    5.1.3 Tumor Biomarkers
    5.1.4 Others
    5.2 Application
    5.2.1 Breast Cancer
    5.2.2 Lung Cancer
    5.2.3 Cervical Cancer
    5.2.4 Kidney Cancer
    5.2.5 Liver Cancer
    5.2.6 Pancreatic Cancer
    5.2.7 Ovarian Cancer
    5.2.8 Others
    5.3 Geography
    5.3.1 North America
    5.3.1.1 US
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 UK
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East and Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East and Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Abbott
    6.1.2 Qiagen
    6.1.3 F. Hoffmann-La Roche Ltd
    6.1.4 Siemens Healthcare GmbH
    6.1.5 Thermo Fisher Scientific Inc.
    6.1.6 GE Healthcare
    6.1.7 Hologic Inc.
    6.1.8 Illumina Inc
    6.1.9 Philips Healthcare
    6.1.10 Agilent Technologies Inc

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Propofol Market 2019 | Estimated Size, Growth Rate, Share, Future Trends of Top Key Players with Forecast to 2025

    Big Data in Healthcare Market 2019 Global Industry Size, Future Trends, Growth Key Factors, Demand, Business Share, Sales & Income, Manufacture Players, Application, Scope, and Opportunities Analysis by Outlook – 2023

    Aesthetics Market 2019 Industry Size, Share, Global Analysis, Development Status, Regional Trends, Opportunity Assessment and Comprehensive Research Study till 2023

    Timing Relay Market 2019 Industry Share, Size, Share, Demand, Key Findings, Regional Analysis, Key Players Profiles, and Forecasts to 2025

  • Be First to Comment

    Leave a Reply

    Your email address will not be published.